Figure 4
From: Solenopsin A and analogs exhibit ceramide-like biological activity
Solenopsin A and analogs reduce oxygen consumption rate. UM-SCC1A cells were plated 15,000/well and treated for 24 h with 10 μM of (+)-solenopsin A ((+) Sol. A), (−)-solenopsin A ((−) Sol. A), and solenopsin analogs S11-S15. Oxygen consumption rate (OCR) was measured as pmoles O2/minute using a Seahorse Biosciences instrument. Data shown are an average of three experiments ± s.d.